T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Coherus Oncology
CHRS
$176M
| $1.06M | ﹤0.01% |
65,154
-3,589
| -5% | -$66.3K |
|
1677
Fabrinet
FN
$20.3B
| $1.05M | ﹤0.01% |
19,309
+8,788
| +84% | +$531K |
|
1678
LXP Industrial Trust
LXP
$3.58B
| $1.05M | ﹤0.01% |
21,115
+1,174
| +6% | +$62.1K |
|
|
ROIC
1679
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.05M | ﹤0.01% |
126,248
+641
| +0.5% | +$9.52K |
|
|
FARO
1680
DELISTED
Faro Technologies
FARO
| $1.05M | ﹤0.01% |
23,506
+120
| +0.5% | +$6.22K |
|
|
TWOU
1681
DELISTED
2U Inc
TWOU
| $1.04M | ﹤0.01% |
1,636
+238
| +17% | +$161K |
|
1682
Southside Bancshares
SBSI
$984M
| $1.04M | ﹤0.01% |
34,099
+3,089
| +10% | +$104K |
|
|
ARNA
1683
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.03M | ﹤0.01% |
24,559
+303
| +1% | +$13.9K |
|
1684
Old National Bancorp
ONB
$10.4B
| $1.03M | ﹤0.01% |
78,027
+6,009
| +8% | +$100K |
|
|
SNV
1685
DELISTED
Synovus
SNV
| $1.03M | ﹤0.01% |
58,571
+156
| +0.3% | +$4.81K |
|
1686
Axos Financial
AX
$5.72B
| $1.02M | ﹤0.01% |
56,328
+379
| +0.7% | +$9.53K |
|
1687
Chemours
CC
$2.3B
| $1.02M | ﹤0.01% |
115,021
+8,526
| +8% | +$123K |
|
|
QUOT
1688
DELISTED
Quotient Technology Inc
QUOT
| $1.02M | ﹤0.01% |
156,934
-17,100
| -10% | -$153K |
|
1689
GATX Corp
GATX
$6.33B
| $1.02M | ﹤0.01% |
16,252
+890
| +6% | +$64.8K |
|
1690
First Merchants
FRME
$2.72B
| $1.02M | ﹤0.01% |
38,353
+2,736
| +8% | +$99.8K |
|
1691
Navient
NAVI
$867M
| $1.01M | ﹤0.01% |
133,538
+36,386
| +37% | +$434K |
|
1692
Sensient Technologies
SXT
$5.53B
| $1.01M | ﹤0.01% |
23,237
+2,445
| +12% | +$135K |
|
1693
Cracker Barrel
CBRL
$1.31B
| $1M | ﹤0.01% |
12,060
+143
| +1% | +$19.6K |
|
|
NSA
1694
DELISTED
National Storage Affiliates Trust
NSA
| $1M | ﹤0.01% |
33,923
-5,822
| -15% | -$193K |
|
|
LMNX
1695
DELISTED
Luminex Corp
LMNX
| $1M | ﹤0.01% |
36,393
-2,660
| -7% | -$65.3K |
|
|
CLDR
1696
DELISTED
Cloudera, Inc.
CLDR
| $1M | ﹤0.01% |
127,245
-1,952
| -2% | -$19.1K |
|
1697
Coeur Mining
CDE
$19B
| $1M | ﹤0.01% |
311,643
+103,079
| +49% | +$536K |
|
|
UMPQ
1698
DELISTED
Umpqua Holdings Corp
UMPQ
| $1M | ﹤0.01% |
91,782
+7,812
| +9% | +$122K |
|
1699
Iridium Communications
IRDM
$5.27B
| $996K | ﹤0.01% |
44,585
+7,095
| +19% | +$184K |
|
1700
RLJ Lodging Trust
RLJ
$1.67B
| $990K | ﹤0.01% |
128,218
+1,181
| +0.9% | +$15.9K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.